SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 15, 2019
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 15, 2019 · CIK: 0000890821 · Accession: 0001140361-19-020688
AI Filing Summary & Sentiment
File numbers found in text: 333-233260
Show Raw Text
CORRESP
1
filename1.htm
AMERI Holdings, Inc.
5000 Research Court, Suite 750,
Suwanee, Georgia, 30024
November 15, 2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Ameri Holdings, Inc.
Registration Statement on Form S-3
File No. 333-233260
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Ameri Holdings, Inc. (the “Company”) respectfully requests that the effective date
of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Tuesday, November 19, 2019, or as soon thereafter as possible.
Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the registration statement has been
declared effective pursuant to this acceleration request.
Respectfully,
Ameri Holdings, Inc.
By:
/s/ Barry Kostiner
Name:
Barry Kostiner
Title:
Chief Financial Officer